Krystal Biotech buy Jefferies Financial Group Inc.
Start price
17.02.26
/
50%
€245.60
Target price
17.02.27
-
Performance (%)
-7.41%
Price
03.03.26
€227.40
Summary
This prediction is currently active. With a performance of -7.41%, the BUY prediction for Krystal Biotech by Jefferies_Financial_ is down slightly. This prediction currently runs until 17.02.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Krystal Biotech | 0.309% |
| iShares Core DAX® | -1,31 % |
| iShares Nasdaq 100 | 1,98 % |
| iShares Nikkei 225® | 0,59 % |
| iShares S&P 500 | 1,42 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€166.55
05.03.25
05.03.25
€228.54
05.03.26
05.03.26
36.54%
03.03.26
03.03.26

